Democritus University of Thrace (DUTH)
Διερεύνηση των επιπέδων των μεταλλοπρωτεϊνασών MMP-2 και MMP-9 σε ασθενείς με ασταθή στηθάγχη και έμφραγμα του μυοκαρδίου
Abstract
dc:descriptionPlaque rupture, with the subsequent thrombus formation, is considered to be the major cause of acute coronary syndromes which range from unstable angina to acute myocardial infarction. Several pathophysiological factors implicate this process, including inflammation, rheological factors, circumferential wall stress and vasoconstriction, as well as degradation of atheromatic plaque elements. Matrix metalloproteinases are very important molecules in the process of vascular remodeling by regulating extracellular matrix degradation. Recently, more and more data have emerged regarding the role of metalloproteinase-2 (MMP-2) and metalloproteinase-9 (MMP-9) in the development of atheromatic plaque. It has been reported that the levels of metalloproteinases are elevated not only in the affected tissue but in the circulating blood as well. These data led us to the hypothesis that patients with degradated atheromatic plaques may have elevated serum levels of metalloproteinases. Therefore, we designed a prospective study to assess the levels of MMP-2 and MMP-9 in patients with unstable angina and acute myocardial infarction. Methods. Our study included 43 patients with acute coronary syndrome (20 with unstable angina, age 69,9±8,5 years and 23 with acute myocardial infarction, age 66,2±11,7 years). Using enzyme sandwich immunoassay (ELISA), we measured MMP-2 and MMP-9 levels in all patients and in 16 healthy controls (age 63,6±7,9 years). Patients’ MMP-2 and MMP-9 levels were measured at the admission and at the 1st, 3rd, 7th and 30th day. In contrast, only one basic measurement was made in the control group. Results. MMP-2 and MMP-9 levels were significantly elevated in all time frames compared to the control group. Patients with unstable angina had elevated MMP-2 levels in all time frames and a significant reduction of MMP-2 in the 30th day. On the contrary, MMP-9 levels remained elevated in all time frames. Patients with acute myocardial infarction had levels of both MMP-2 and MMP-9 in all time frames without significant differences. A meta-analysis of subgroups of patients who received statins, showed an augmented influence of statin therapy, with a significant reduction of MMP-9 in patients with unstable angina. The correlation of MMP-2 and MMP-9 with CRP levels showed no parallel course of these markers in both patient groups. Conclusions. Differences in the time course of MMP-2 and MMP-9 were observed in patients with acute coronary syndromes. These differences reflect the changes and the modification that take place in the molecular level during the process of atheromatic plaque degradation in the coronary vessels. The time course of CRP, the major inflammatory marker, differs from the time course of post-inflammatory markers such as matrix metalloproteinases.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2005
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Φλώρος, Δημήτριος
- Floros, Dimitrios
Subjects
dc:subject × 20- Μεταλλοπρωτεϊνάσες
- Ασταθής στηθάγχη
- Μυοκάρδιο, Έμφραγμα του
- Οξέα στεφανιαία σύνδρομα
- Αθηροσκλήρυνση
- Φλεγμονές
- C αντιδρώσα πρωτεΐνη
- Στατίνες
- Metalloproteinases
- Unstable angina
- Myocardial infarction
- Acute coronary syndromes
- Atherosclerosis
- Inflammation
- C reactive protein (CRP)
- Statins
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/17251